The Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years of age and older and high-risk individuals aged 12-64 years.

Pyzchiva® is a key biosimilar value driver for the Sandoz growth strategy. It has been launched in 23 markets in Europe. The autoinjector is now available in Spain and will continue to roll out across ...

ANIP is expected to raise 2025 guidance due to FDA approval and launch of TEZRULY and INZIRQO, addressing unmet needs for dysphagic patients.

The Autoinjectors Market is expected to witness a growth rate of 14-16% by 2028. The key factors driving the market are the ...

Insulin is absolutely necessary for people with type 1 diabetes ... additional costs tied to prefilled insulin pens or expensive diabetes pump devices. A box of 100 syringes may cost between ...

Novavax Inc. drew retail attention on Friday after receiving a Biologics License Application for its COVID-19 vaccine, ...

The drug comes in two forms: a disposable, prefilled FlexTouch injection ... 200 units of insulin degludec per 1 mL of solution Vial for use with syringes: This form of Tresiba contains 10 mL ...

Teva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi (ustekinumab-aekn) injection as interchangeable with reference biologic ...

Approved presentations of SELARSDI are 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous injection ... and inflammatory diseases like Crohn's disease and ulcerative colitis ...